Filed 21d ago· May 13, 2026
41 days to disclose
Byron Donalds
RHouseFlorida-19
↑bought
Eli Lilly
LLY
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 2, 2026
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–100 of 251
Filed 21d ago· May 13, 2026
41 days to discloseByron Donalds
RHouseFlorida-19
↑bought
Eli Lilly
LLY
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 2, 2026
SP Eli Lilly and Company
Filed 26d ago· May 8, 2026
Donald J. Trump
RPOTUSFlorida
↑bought
AbbVie
ABBV
$50K-$100K
+5.1% vs S&P 500
Trade dateMay 8, 2026
Filed 26d ago· May 8, 2026
Donald J. Trump
RPOTUSFlorida
↑bought
Vertex Pharmaceuticals
VRTX
$15K+
Trade dateMay 8, 2026
Filed 26d ago· May 8, 2026
Donald J. Trump
RPOTUSFlorida
↑bought
Bristol-Myers Squibb
BMY
$15K-$50K
Trade dateMay 8, 2026
BRISTOL MYERS SQUIBB CO UNSOLICITED
Filed 1mo ago· Apr 6, 2026
27 days to disclose
Lloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−2.1% vs S&P 500
Trade dateMar 10, 2026
⚑ Pharmaceutical
Filed 2mo ago· Mar 6, 2026
8 days to disclose
David J. Taylor
RHouseOhio-02
↑bought
Eli Lilly
LLY
$1K-$15K
+8.9% vs S&P 500
Trade dateFeb 26, 2026
Filed 2mo ago· Mar 6, 2026
8 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Amgen
AMGN
$1K-$15K
−5.7% vs S&P 500
Trade dateFeb 26, 2026
Filed 3mo ago· Feb 26, 2026
30 days to disclose
Josh Gottheimer
DHouseNew Jersey-05
↑bought
Gilead Sciences
GILD
$1K-$15K
+0.3% vs S&P 500
Trade dateJan 27, 2026
Filed 3mo ago· Feb 20, 2026
11 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Eli Lilly
LLY
$1K-$15K
−5.0% vs S&P 500
Trade dateFeb 9, 2026
Filed 4mo ago· Feb 2, 2026
4 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
−3.5% vs S&P 500
Trade dateJan 29, 2026
-
Filed 4mo ago· Feb 2, 2026
4 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Amgen
AMGN
$1K-$15K
−3.5% vs S&P 500
Trade dateJan 29, 2026
Filed 4mo ago· Feb 2, 2026
17 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Eli Lilly
LLY
$1K-$15K
−4.6% vs S&P 500
Trade dateJan 16, 2026
Filed 4mo ago· Feb 2, 2026
17 days to discloseDavid J. Taylor
RHouseOhio-02
↑bought
Amgen
AMGN
$1K-$15K
+3.8% vs S&P 500
Trade dateJan 16, 2026
Filed 4mo ago· Jan 13, 2026
36 days to disclose
Julia Letlow
RHouseLouisiana-05
↑bought
AstraZeneca
AZN
$1K-$15K
+3.2% vs S&P 500
Trade dateDec 8, 2025
Depositary Shares
Filed 4mo ago· Jan 12, 2026
25 days to disclose
Gilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
AstraZeneca
AZN
$1K-$15K
+5.6% vs S&P 500
Trade dateDec 18, 2025
Depositary Shares
Filed 5mo ago· Jan 2, 2026
24 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+16.6% vs S&P 500
Trade dateDec 9, 2025
⚑ Pharmaceutical
Filed 5mo ago· Dec 19, 2025
9 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Eli Lilly
LLY
$1K-$15K
−2.4% vs S&P 500
Trade dateDec 10, 2025
Filed 5mo ago· Dec 15, 2025
26 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
AstraZeneca
AZN
$1K-$15K
+6.4% vs S&P 500
Trade dateNov 19, 2025
Depositary Shares
Filed 6mo ago· Dec 5, 2025
2 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Amgen
AMGN
$1K-$15K
−4.2% vs S&P 500
Trade dateDec 3, 2025
Filed 6mo ago· Dec 5, 2025
2 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Amgen
AMGN
$1K-$15K
−4.2% vs S&P 500
Trade dateDec 3, 2025
Filed 6mo ago· Nov 21, 2025
21 days to disclose
Lisa C. McClain
RHouseMichigan-09
↓sold
AstraZeneca
AZN
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 31, 2025
Depositary Shares
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
21 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
GSK PLC
GSK
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 31, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
GSK PLC
GSK
$1K-$15K
+4.7% vs S&P 500
Trade dateOct 30, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
AstraZeneca
AZN
$1K-$15K
+2.9% vs S&P 500
Trade dateOct 30, 2025
Depositary Shares
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
GSK PLC
GSK
$1K-$15K
+2.9% vs S&P 500
Trade dateOct 30, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
AstraZeneca
AZN
$1K-$15K
+9.4% vs S&P 500
Trade dateOct 30, 2025
Depositary Shares
⚑ Pharmaceutical
Filed 6mo ago· Nov 18, 2025
28 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
AstraZeneca
AZN
$1K-$15K
+8.8% vs S&P 500
Trade dateOct 21, 2025
Depositary Shares
Filed 7mo ago· Oct 22, 2025
41 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Sanofi
SNY
$1K-$15K
+6.3% vs S&P 500
Trade dateSep 11, 2025
⚑ Pharmaceutical
Filed 7mo ago· Oct 10, 2025
17 days to disclose
Val T. Hoyle
DHouseOregon-04
↓sold
AstraZeneca
AZN
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Depositary Shares
Filed 7mo ago· Oct 10, 2025
17 days to discloseVal T. Hoyle
DHouseOregon-04
↓sold
Gilead Sciences
GILD
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Filed 7mo ago· Oct 10, 2025
17 days to discloseVal T. Hoyle
DHouseOregon-04
↓sold
GSK PLC
GSK
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Filed 8mo ago· Sep 12, 2025
39 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
Sanofi
SNY
$1K-$15K
−20.6% vs S&P 500
Trade dateAug 4, 2025
⚑ Pharmaceutical
Filed 8mo ago· Sep 12, 2025
39 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
GSK PLC
GSK
$1K-$15K
+22.4% vs S&P 500
Trade dateAug 4, 2025
⚑ Pharmaceutical
Filed 8mo ago· Sep 12, 2025
298 days to disclose · 253 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
GSK PLC
GSK
$1K-$15K
+45.4% vs S&P 500
Trade dateNov 18, 2024
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
Gilead Sciences
GILD
$1K-$15K
+37.9% vs S&P 500
Trade dateOct 29, 2024
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
AstraZeneca
AZN
$1K-$15K
+42.9% vs S&P 500
Trade dateOct 29, 2024
Depositary Shares
Filed 8mo ago· Sep 10, 2025
44 days to disclose
Robert B. Aderholt
RHouseAlabama-04
↓sold
GSK PLC
GSK
$1K-$15K
+9.8% vs S&P 500
Trade dateJul 28, 2025
Filed 9mo ago· Sep 2, 2025
19 days to discloseDavid J. Taylor
RHouseOhio-02
↑bought
Eli Lilly
LLY
$1K-$15K
+43.4% vs S&P 500
Trade dateAug 14, 2025
Filed 9mo ago· Sep 2, 2025
19 days to discloseDavid J. Taylor
RHouseOhio-02
↑bought
Eli Lilly
LLY
$15K-$50K
+43.4% vs S&P 500
Trade dateAug 14, 2025
Filed 9mo ago· Sep 2, 2025
26 days to discloseDavid J. Taylor
RHouseOhio-02
↑bought
Vertex Pharmaceuticals
VRTX
$1K-$15K
−2.9% vs S&P 500
Trade dateAug 7, 2025
-
Filed 9mo ago· Aug 20, 2025
190 days to disclose · 145 past 45-day window
Daniel Meuser
RHousePennsylvania-09
↓sold
Amgen
AMGN
$1K-$15K
+1.7% vs S&P 500
Trade dateFeb 11, 2025
Filed 9mo ago· Aug 13, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
AstraZeneca
AZN
$1K-$15K
+20.0% vs S&P 500
Trade dateJul 22, 2025
Depositary Shares
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Sanofi
SNY
$1K-$15K
+11.2% vs S&P 500
Trade dateJul 22, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
50 days to disclose · 5 past 45-day windowLisa C. McClain
RHouseMichigan-09
↓sold
GSK PLC
GSK
$1K-$15K
+11.0% vs S&P 500
Trade dateJun 24, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
57 days to disclose · 12 past 45-day windowLisa C. McClain
RHouseMichigan-09
↓sold
AstraZeneca
AZN
$1K-$15K
+11.3% vs S&P 500
Trade dateJun 17, 2025
Depositary Shares
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
57 days to disclose · 12 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
GSK PLC
GSK
$1K-$15K
+15.9% vs S&P 500
Trade dateJun 17, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
57 days to disclose · 12 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
Sanofi
SNY
$1K-$15K
−20.5% vs S&P 500
Trade dateJun 17, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
65 days to disclose · 20 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
AstraZeneca
AZN
$1K-$15K
+15.9% vs S&P 500
Trade dateJun 9, 2025
Depositary Shares
⚑ Pharmaceutical
Filed 11mo ago· Jul 7, 2025
27 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+38.4% vs S&P 500
Trade dateJun 10, 2025
⚑ Pharmaceutical
Filed 11mo ago· Jun 22, 2025
41 days to disclose
Jefferson Shreve
RHouseIndiana-06
↓sold
Gilead Sciences
GILD
$15K-$50K
+9.2% vs S&P 500
Trade dateMay 12, 2025
Filed 11mo ago· Jun 18, 2025
12 days to disclose
Marjorie Taylor Greene
RHouseGeorgia-14
↑bought
Gilead Sciences
GILD
$1K-$15K
+9.6% vs S&P 500
Trade dateJun 6, 2025
Filed 11mo ago· Jun 11, 2025
28 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Gilead Sciences
GILD
$1K-$15K
+15.3% vs S&P 500
Trade dateMay 14, 2025
Filed 1.0y ago· May 24, 2025
44 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
+10.1% vs S&P 500
Trade dateApr 10, 2025
Common Stock
Filed 1.0y ago· May 24, 2025
44 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
+10.1% vs S&P 500
Trade dateApr 10, 2025
Common Stock
Filed 1.0y ago· May 16, 2025
35 days to disclose
Dan Newhouse
RHouseWashington-04
↓sold
Eli Lilly
LLY
$1K-$15K
+8.5% vs S&P 500
Trade dateApr 11, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 14, 2025
28 days to disclose
John Boozman
RSenateArkansas
↓sold
Gilead Sciences
GILD
$1K-$15K
+9.0% vs S&P 500
Trade dateApr 16, 2025
Filed 1.1y ago· May 12, 2025
21 days to disclose
Bruce Westerman
RHouseArkansas-04
↓sold
AstraZeneca
AZN
$1K-$15K
+12.0% vs S&P 500
Trade dateApr 21, 2025
Depositary Shares
Filed 1.1y ago· May 12, 2025
21 days to discloseBruce Westerman
RHouseArkansas-04
↓sold
GSK PLC
GSK
$1K-$15K
+12.0% vs S&P 500
Trade dateApr 21, 2025
Filed 1.1y ago· May 6, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Gilead Sciences
GILD
$1K-$15K
+23.9% vs S&P 500
Trade dateMay 5, 2025
Filed 1.1y ago· May 6, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Gilead Sciences
GILD
$1K-$15K
+23.9% vs S&P 500
Trade dateMay 5, 2025
Filed 1.1y ago· Apr 17, 2025
14 days to disclose
Dwight Evans
DHousePennsylvania-03
↓sold
AbbVie
ABBV
$1K-$15K
+3.8% vs S&P 500
Trade dateApr 3, 2025
⚑ Pharmaceutical
Filed 1.1y ago· Apr 16, 2025
44 days to discloseBruce Westerman
RHouseArkansas-04
↑bought
AstraZeneca
AZN
$1K-$15K
+22.2% vs S&P 500
Trade dateMar 3, 2025
Depositary Shares
Filed 1.1y ago· Apr 16, 2025
44 days to discloseBruce Westerman
RHouseArkansas-04
↑bought
GSK PLC
GSK
$1K-$15K
+33.9% vs S&P 500
Trade dateMar 3, 2025
Filed 1.1y ago· Apr 14, 2025
25 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 20, 2025
-
Filed 1.1y ago· Apr 14, 2025
25 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 20, 2025
-
Filed 1.1y ago· Apr 14, 2025
25 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Novo Nordisk
NVO
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 20, 2025
Filed 1.1y ago· Apr 14, 2025
25 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Novo Nordisk
NVO
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 20, 2025
Filed 1.1y ago· Apr 11, 2025
11 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Gilead Sciences
GILD
$15K-$50K
+18.9% vs S&P 500
Trade dateMar 31, 2025
Filed 1.1y ago· Apr 11, 2025
32 days to disclose
Carol D. Miller
RHouseWest Virginia-01
↑bought
Gilead Sciences
GILD
$1K-$15K
+14.7% vs S&P 500
Trade dateMar 10, 2025
⚑ Pharmaceutical
Filed 1.1y ago· Apr 11, 2025
32 days to discloseCarol D. Miller
RHouseWest Virginia-01
↓sold
Pfizer
PFE
$1K-$15K
+0.6% vs S&P 500
Trade dateMar 10, 2025
Pfizer, Inc.
⚑ Pharmaceutical
Filed 1.1y ago· Apr 10, 2025
34 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Gilead Sciences
GILD
$1K-$15K
+15.6% vs S&P 500
Trade dateMar 7, 2025
Filed 1.2y ago· Apr 7, 2025
34 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+39.6% vs S&P 500
Trade dateMar 4, 2025
⚑ Pharmaceutical
Filed 1.3y ago· Feb 10, 2025
25 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Merck
MRK
$1K-$15K
+5.2% vs S&P 500
Trade dateJan 16, 2025
Stock
Filed 1.3y ago· Feb 10, 2025
25 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Merck
MRK
$1K-$15K
+5.2% vs S&P 500
Trade dateJan 16, 2025
Stock
Filed 1.4y ago· Jan 8, 2025
29 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+51.9% vs S&P 500
Trade dateDec 10, 2024
⚑ Pharmaceutical
Filed 1.4y ago· Dec 27, 2024
3 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Gilead Sciences
GILD
$1K-$15K
+37.2% vs S&P 500
Trade dateDec 24, 2024
Filed 1.5y ago· Nov 27, 2024
2 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
GSK PLC
GSK
$1K-$15K
+45.8% vs S&P 500
Trade dateNov 25, 2024
Filed 1.6y ago· Oct 10, 2024
30 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+42.8% vs S&P 500
Trade dateSep 10, 2024
⚑ Pharmaceutical
Filed 1.7y ago· Sep 6, 2024
2 days to disclose
John James
RHouseMichigan-10
↓sold
Sanofi
SNY
$1K-$15K
−5.2% vs S&P 500
Trade dateSep 4, 2024
⚑ Pharmaceutical
Filed 1.8y ago· Sep 2, 2024
297 days to disclose · 252 past 45-day windowJohn James
RHouseMichigan-10
↑bought
Sanofi
SNY
$1K-$15K
−22.3% vs S&P 500
Trade dateNov 10, 2023
⚑ Pharmaceutical
Filed 1.8y ago· Aug 6, 2024
403 days to disclose · 358 past 45-day window
David P. Joyce
RHouseOhio-14
↓sold
S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024
XBI
$15K-$50K
+11.9% vs S&P 500
Trade dateJun 30, 2023
ETF
Filed 1.9y ago· Jul 3, 2024
29 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+18.8% vs S&P 500
Trade dateJun 4, 2024
⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
35 days to disclose
Tommy Tuberville
RSenateAlabama
↑bought
Gilead Sciences
GILD
$1K-$15K
+60.6% vs S&P 500
Trade dateMay 10, 2024
Option⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
35 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Gilead Sciences
GILD
$1K-$15K
+60.6% vs S&P 500
Trade dateMay 10, 2024
Option⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
35 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Gilead Sciences
GILD
$1K-$15K
+60.6% vs S&P 500
Trade dateMay 10, 2024
Option⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
37 days to discloseTommy Tuberville
RSenateAlabama
↑bought
S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024
XBI
$1K-$15K
+11.5% vs S&P 500
Trade dateMay 8, 2024
S&P Biotech SPDR Option Type: Call Strike price: $100.00 Expires: 10/18/2024
Option⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
37 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Gilead Sciences
GILD
$1K-$15K
−62.8% vs S&P 500
Trade dateMay 8, 2024
Gilead Sciences, Inc. -
⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
37 days to discloseTommy Tuberville
RSenateAlabama
↑bought
S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024
XBI
$1K-$15K
+11.5% vs S&P 500
Trade dateMay 8, 2024
Option⚑ Pharmaceutical
Filed 2.0y ago· May 20, 2024
41 days to disclose
Sheldon Whitehouse
DSenateRhode Island
↓sold
Novartis Ag
NVS
$1K-$15K
−14.4% vs S&P 500
Trade dateApr 9, 2024
⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
40 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Gilead Sciences
GILD
$1K-$15K
+49.7% vs S&P 500
Trade dateApr 5, 2024
Gilead Sciences, Inc. -
⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Gilead Sciences
GILD
$1K-$15K
−46.5% vs S&P 500
Trade dateApr 3, 2024
Gilead Sciences, Inc. - Common Stock Option Type: Put Strike price: $70.00 Expires: 11/15/2024
Option⚑ Pharmaceutical
Filed 2.1y ago· Apr 25, 2024
15 days to discloseDan Newhouse
RHouseWashington-04
↓sold
Eli Lilly
LLY
$1K-$15K
+22.9% vs S&P 500
Trade dateApr 10, 2024
⚑ Pharmaceutical
Filed 2.2y ago· Apr 9, 2024
35 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+1.4% vs S&P 500
Trade dateMar 5, 2024
⚑ Pharmaceutical
Filed 2.4y ago· Jan 24, 2024
5 days to disclose
Blake D. Moore
RHouseUtah-01
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+6.5% vs S&P 500
Trade dateJan 19, 2024
⚑ Pharmaceutical
Filed 2.4y ago· Jan 24, 2024
5 days to discloseBlake D. Moore
RHouseUtah-01
↓sold
Johnson & Johnson
JNJ
$15K-$30K
+6.5% vs S&P 500
Trade dateJan 19, 2024
⚑ Pharmaceutical
Filed 2.4y ago· Jan 8, 2024
27 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+37.2% vs S&P 500
Trade dateDec 12, 2023
⚑ Pharmaceutical
Filed 2.5y ago· Nov 16, 2023
31 days to discloseTommy Tuberville
RSenateAlabama
↓sold
GSK PLC
GSK
$1K-$15K
+14.9% vs S&P 500
Trade dateOct 16, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Oct 17, 2023
27 days to discloseSheldon Whitehouse
DSenateRhode Island
↑bought
Novartis Ag
NVS
$15K-$50K
−22.3% vs S&P 500
Trade dateSep 20, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Oct 15, 2023
30 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
CSPC PHARMS GRP U/
CSPCY
$1K-$15K
+12.3% vs S&P 500
Trade dateSep 15, 2023
JT CSPC PHARMS GRP U/ADR
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 13, 2026 21d ago | Byron Donalds RHouseFlorida-19 | ↑bought | Eli Lilly LLY | Apr 2, 2026 41 days to disclose | Good buy·+$1K+12.8% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 13, 2026 21d ago | Byron Donalds RHouseFlorida-19 | ↑bought | Eli Lilly LLY SP Eli Lilly and Company | Apr 2, 2026 41 days to disclose | Good buy·+$1K+12.8% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2026 26d ago | Donald J. Trump RPOTUSFlorida | ↑bought | AbbVie ABBV | May 8, 2026 | Good buy·+$4.8K+6.3% +5.1% vs S&P 500 | $50K-$100K midpoint $75K |
May 8, 2026 26d ago | Donald J. Trump RPOTUSFlorida | ↑bought | Vertex Pharmaceuticals VRTX | May 8, 2026 | price pending | $15K+ midpoint $15K |
May 8, 2026 26d ago | Donald J. Trump RPOTUSFlorida | ↑bought | Bristol-Myers Squibb BMY BRISTOL MYERS SQUIBB CO UNSOLICITED | May 8, 2026 | price pending | $15K-$50K midpoint $32.5K |
Apr 6, 2026 1mo ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 10, 2026 27 days to disclose | Bad buy·−$407-5.1% −2.1% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 6, 2026 2mo ago | David J. Taylor RHouseOhio-02 | ↑bought | Eli Lilly LLY | Feb 26, 2026 8 days to disclose | Good buy·+$262+3.3% +8.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 6, 2026 2mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Amgen AMGN | Feb 26, 2026 8 days to disclose | Flat·+0.0% −5.7% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 26, 2026 3mo ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Gilead Sciences GILD | Jan 27, 2026 30 days to disclose | Bad buy·−$333-4.2% +0.3% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 20, 2026 3mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Eli Lilly LLY | Feb 9, 2026 11 days to disclose | Flat·+0.0% −5.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 2, 2026 4mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Vertex Pharmaceuticals VRTX - | Jan 29, 2026 4 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 2, 2026 4mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Amgen AMGN | Jan 29, 2026 4 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 2, 2026 4mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Eli Lilly LLY | Jan 16, 2026 17 days to disclose | Flat·+0.0% −4.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 2, 2026 4mo ago | David J. Taylor RHouseOhio-02 | ↑bought | Amgen AMGN | Jan 16, 2026 17 days to disclose | Bad buy·−$69-0.9% +3.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | AstraZeneca AZN Depositary Shares | Dec 8, 2025 36 days to disclose | Good buy·+$103+1.3% +3.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2026 4mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | AstraZeneca AZN Depositary Shares | Dec 18, 2025 25 days to disclose | Good buy·+$163+2.0% +5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 2, 2026 5mo ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Dec 9, 2025 24 days to disclose | Good buy·+$1.3K+15.7% +16.6% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 19, 2025 5mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Eli Lilly LLY | Dec 10, 2025 9 days to disclose | Flat·+0.0% −2.4% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2025 5mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | AstraZeneca AZN Depositary Shares | Nov 19, 2025 26 days to disclose | Good buy·+$312+3.9% +6.4% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2025 6mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Amgen AMGN | Dec 3, 2025 2 days to disclose | Flat·+0.0% −4.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2025 6mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Amgen AMGN | Dec 3, 2025 2 days to disclose | Flat·+0.0% −4.2% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | AstraZeneca AZN Depositary Shares ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | GSK PLC GSK ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | GSK PLC GSK ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Good buy·+$612+7.6% +4.7% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | AstraZeneca AZN Depositary Shares ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | GSK PLC GSK ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | AstraZeneca AZN Depositary Shares ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Good buy·+$983+12.3% +9.4% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 18, 2025 6mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | AstraZeneca AZN Depositary Shares | Oct 21, 2025 28 days to disclose | Good buy·+$888+11.1% +8.8% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 22, 2025 7mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Sanofi SNY ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Sep 11, 2025 41 days to disclose | Flat·+0.0% +6.3% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | AstraZeneca AZN Depositary Shares | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | Gilead Sciences GILD | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | GSK PLC GSK | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Sanofi SNY ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Aug 4, 2025 39 days to disclose | Bad buy·−$713-8.9% −20.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | GSK PLC GSK ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Aug 4, 2025 39 days to disclose | Good buy·+$2.7K+34.1% +22.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | GSK PLC GSK | Nov 18, 2024 298 days to disclose · 253 past 45-day window | Good buy·+$4K+50.0% +45.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | Gilead Sciences GILD | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$3K+38.0% +37.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | AstraZeneca AZN Depositary Shares | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$3.4K+42.9% +42.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 10, 2025 8mo ago | Robert B. Aderholt RHouseAlabama-04 | ↓sold | GSK PLC GSK | Jul 28, 2025 44 days to disclose | Flat·+0.0% +9.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2025 9mo ago | David J. Taylor RHouseOhio-02 | ↑bought | Eli Lilly LLY | Aug 14, 2025 19 days to disclose | Good buy·+$4.3K+54.2% +43.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2025 9mo ago | David J. Taylor RHouseOhio-02 | ↑bought | Eli Lilly LLY | Aug 14, 2025 19 days to disclose | Good buy·+$17.6K+54.2% +43.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 2, 2025 9mo ago | David J. Taylor RHouseOhio-02 | ↑bought | Vertex Pharmaceuticals VRTX - | Aug 7, 2025 26 days to disclose | Good buy·+$977+12.2% −2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2025 9mo ago | Daniel Meuser RHousePennsylvania-09 | ↓sold | Amgen AMGN | Feb 11, 2025 190 days to disclose · 145 past 45-day window | Flat·+0.0% +1.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | AstraZeneca AZN Depositary Shares ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 22, 2025 22 days to disclose | Good buy·+$2.5K+31.2% +20.0% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Sanofi SNY ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 22, 2025 22 days to disclose | Flat·+0.0% +11.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | GSK PLC GSK ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 24, 2025 50 days to disclose · 5 past 45-day window | Flat·+0.0% +11.0% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | AstraZeneca AZN Depositary Shares ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 17, 2025 57 days to disclose · 12 past 45-day window | Flat·+0.0% +11.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | GSK PLC GSK ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 17, 2025 57 days to disclose · 12 past 45-day window | Good buy·+$2.2K+27.2% +15.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Sanofi SNY ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 17, 2025 57 days to disclose · 12 past 45-day window | Bad buy·−$738-9.2% −20.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | AstraZeneca AZN Depositary Shares ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 9, 2025 65 days to disclose · 20 past 45-day window | Good buy·+$2.1K+26.6% +15.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 7, 2025 11mo ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jun 10, 2025 27 days to disclose | Good buy·+$3.8K+47.8% +38.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 22, 2025 11mo ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Gilead Sciences GILD | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 18, 2025 11mo ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Gilead Sciences GILD | Jun 6, 2025 12 days to disclose | Good buy·+$1.6K+20.1% +9.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2025 11mo ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Gilead Sciences GILD | May 14, 2025 28 days to disclose | Flat·+0.0% +15.3% vs S&P 500 | $1K-$15K midpoint $8K |
May 24, 2025 1.0y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Regeneron Pharmaceuticals REGN Common Stock | Apr 10, 2025 44 days to disclose | Flat·+0.0% +10.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 24, 2025 1.0y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Regeneron Pharmaceuticals REGN Common Stock | Apr 10, 2025 44 days to disclose | Flat·+0.0% +10.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 16, 2025 1.0y ago | Dan Newhouse RHouseWashington-04 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 11, 2025 35 days to disclose | Flat·+0.0% +8.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | John Boozman RSenateArkansas | ↓sold | Gilead Sciences GILD | Apr 16, 2025 28 days to disclose | Flat·+0.0% +9.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2025 1.1y ago | Bruce Westerman RHouseArkansas-04 | ↓sold | AstraZeneca AZN Depositary Shares | Apr 21, 2025 21 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2025 1.1y ago | Bruce Westerman RHouseArkansas-04 | ↓sold | GSK PLC GSK | Apr 21, 2025 21 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Gilead Sciences GILD | May 5, 2025 1 day to disclose | Good buy·+$2.5K+31.4% +23.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Gilead Sciences GILD | May 5, 2025 1 day to disclose | Good buy·+$2.5K+31.4% +23.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2025 1.1y ago | Dwight Evans DHousePennsylvania-03 | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Ways and Means | Apr 3, 2025 14 days to disclose | Flat·+0.0% +3.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | Bruce Westerman RHouseArkansas-04 | ↑bought | AstraZeneca AZN Depositary Shares | Mar 3, 2025 44 days to disclose | Good buy·+$1.7K+21.5% +22.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | Bruce Westerman RHouseArkansas-04 | ↑bought | GSK PLC GSK | Mar 3, 2025 44 days to disclose | Good buy·+$2.7K+33.1% +33.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Vertex Pharmaceuticals VRTX - | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Vertex Pharmaceuticals VRTX - | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Novo Nordisk NVO | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Novo Nordisk NVO | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Gilead Sciences GILD | Mar 31, 2025 11 days to disclose | Good buy·+$6.7K+20.6% +18.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | Carol D. Miller RHouseWest Virginia-01 | ↑bought | Gilead Sciences GILD ⚑ Pharmaceutical · Ways and Means | Mar 10, 2025 32 days to disclose | Good buy·+$1.2K+15.3% +14.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | Carol D. Miller RHouseWest Virginia-01 | ↓sold | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Ways and Means | Mar 10, 2025 32 days to disclose | Flat·+0.0% +0.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 10, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Gilead Sciences GILD | Mar 7, 2025 34 days to disclose | Good buy·+$1.2K+15.1% +15.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 4, 2025 34 days to disclose | Good buy·+$3.2K+39.8% +39.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Merck MRK Stock | Jan 16, 2025 25 days to disclose | Flat·+0.0% +5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Merck MRK Stock | Jan 16, 2025 25 days to disclose | Flat·+0.0% +5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 8, 2025 1.4y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Dec 10, 2024 29 days to disclose | Good buy·+$4.4K+55.0% +51.9% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 27, 2024 1.4y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Gilead Sciences GILD | Dec 24, 2024 3 days to disclose | Good buy·+$3.5K+43.8% +37.2% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 27, 2024 1.5y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | GSK PLC GSK | Nov 25, 2024 2 days to disclose | Good buy·+$3.8K+48.0% +45.8% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2024 1.6y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Sep 10, 2024 30 days to disclose | Good buy·+$3.1K+38.2% +42.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 6, 2024 1.7y ago | John James RHouseMichigan-10 | ↓sold | Sanofi SNY ⚑ Pharmaceutical · Energy and Commerce | Sep 4, 2024 2 days to disclose | Flat·+0.0% −5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2024 1.8y ago | John James RHouseMichigan-10 | ↑bought | Sanofi SNY ⚑ Pharmaceutical · Energy and Commerce | Nov 10, 2023 297 days to disclose · 252 past 45-day window | Bad buy·−$375-4.7% −22.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 6, 2024 1.8y ago | David P. Joyce RHouseOhio-14 | ↓sold | S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024 XBI ETF | Jun 30, 2023 403 days to disclose · 358 past 45-day window | Flat·+0.0% +11.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jul 3, 2024 1.9y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jun 4, 2024 29 days to disclose | Good buy·+$4.3K+53.9% +18.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↑bought | Gilead Sciences GILD Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 10, 2024 35 days to disclose | Good buy·+$7.8K+97.7% +60.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↑bought | Gilead Sciences GILD Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 10, 2024 35 days to disclose | Good buy·+$7.8K+97.7% +60.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↑bought | Gilead Sciences GILD Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 10, 2024 35 days to disclose | Good buy·+$7.8K+97.7% +60.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↑bought | S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024 XBI S&P Biotech SPDR Option Type: Call Strike price: $100.00 Expires: 10/18/2024 Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 8, 2024 37 days to disclose | Good buy·+$4K+49.6% +11.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↓sold | Gilead Sciences GILD Gilead Sciences, Inc. - ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 8, 2024 37 days to disclose | Missed gain·−$8.1K-100.9% −62.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↑bought | S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024 XBI Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 8, 2024 37 days to disclose | Good buy·+$4K+49.6% +11.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 20, 2024 2.0y ago | Sheldon Whitehouse DSenateRhode Island | ↓sold | Novartis Ag NVS ⚑ Pharmaceutical · Commerce, Science, and Transportation | Apr 9, 2024 41 days to disclose | Missed gain·−$4.1K-51.8% −14.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↑bought | Gilead Sciences GILD Gilead Sciences, Inc. - ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 5, 2024 40 days to disclose | Good buy·+$7K+87.4% +49.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Gilead Sciences GILD Gilead Sciences, Inc. - Common Stock Option Type: Put Strike price: $70.00 Expires: 11/15/2024 Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2024 42 days to disclose | Missed gain·−$6.7K-83.9% −46.5% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 25, 2024 2.1y ago | Dan Newhouse RHouseWashington-04 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 10, 2024 15 days to disclose | Missed gain·−$1.3K-16.0% +22.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 9, 2024 2.2y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 5, 2024 35 days to disclose | Good buy·+$3.4K+42.2% +1.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 24, 2024 2.4y ago | Blake D. Moore RHouseUtah-01 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jan 19, 2024 5 days to disclose | Flat·+0.0% +6.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 24, 2024 2.4y ago | Blake D. Moore RHouseUtah-01 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jan 19, 2024 5 days to disclose | Flat·+0.0% +6.5% vs S&P 500 | $15K-$30K midpoint $22.5K |
Jan 8, 2024 2.4y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Dec 12, 2023 27 days to disclose | Good buy·+$3.9K+48.5% +37.2% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2023 2.5y ago | Tommy Tuberville RSenateAlabama | ↓sold | GSK PLC GSK ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 16, 2023 31 days to disclose | Missed gain·−$3.9K-48.8% +14.9% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 17, 2023 2.6y ago | Sheldon Whitehouse DSenateRhode Island | ↑bought | Novartis Ag NVS ⚑ Pharmaceutical · Commerce, Science, and Transportation | Sep 20, 2023 27 days to disclose | Good buy·+$13.1K+40.4% −22.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 15, 2023 2.6y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | CSPC PHARMS GRP U/ CSPCY JT CSPC PHARMS GRP U/ADR | Sep 15, 2023 30 days to disclose | Flat·+0.0% +12.3% vs S&P 500 | $1K-$15K midpoint $8K |